Skip to main content
FinSpry Logo
FinSpry
EMBC logo
EMBC
(NASDAQ)
Embecta Corp.
$8.85-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Embecta (EMBC) Stock Price & Financial Analysis

Embecta Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$8.51 - $8.96
52-Week High$15.55
52-Week Low$8.47
Open$8.66
Volume1.08M
Average Volume (3M)1.08M
Market Cap524.72M
Shares Outstanding59.29M
P/E Ratio (TTM)3.74
Forward P/E1.87
Price to Sales (P/S)0.48
EV/EBITDA4.93
Revenue (TTM)1.08B
Net Income (TTM)139.50M
Free Cash Flow (TTM)205.80M
EPS (TTM)$2.35
Profit Margin12.92%
Operating Margin29.57%
50-Day MA$9.90
200-Day MA$11.98
52-Week Change-30.40%
Annual Dividend$0.60
Dividend Yield6.83%
Payout Ratio25.50%
Last Dividend Ex-DateFeb 27, 2026

Frequently Asked Questions About Embecta

What is the current stock price for EMBC?

As of the latest trading session, EMBC stock trades at $8.85. The 52-week range is $8.47–$15.55, with a day range of $8.51–$8.96.

What is the P/E ratio for EMBC?

Embecta's trailing P/E ratio is 3.7, meaning investors pay $3.7 for every $1 of annual earnings. The forward P/E is 1.9, reflecting analyst expectations for future earnings. Embecta operates in the Healthcare sector.

Does EMBC pay dividends?

Yes, Embecta pays a 6.83% annual dividend yield ($0.60 per share). The payout ratio is 25.5%. The last ex-dividend date was 2026-02-27.

What do analysts recommend for EMBC?

Based on 1 analyst, the consensus for EMBC is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of EMBC?

Embecta's market capitalization is $524.7M, classifying it as a small-cap company. Embecta operates in the Healthcare sector within the Medical Instruments & Supplies industry.